EN
HI

Venmax Drugs And Pharmaceuticals Share price

VENMAX

HealthcareSmall

24.7

0.08 (0.32%)
Last updated on 30 May, 2025 | 14:48 IST
BUYSELL
Today's High

25.20

Today's Low

23.41

52 Week Low

6.27

52 Week High

30.88

The current prices are delayed, login to your account for live prices

Venmax Drugs And Pharmaceuticals Chart

Venmax Drugs And Pharmaceuticals Share Key Metrics

Volume
12687.00
Market Cap
12.90 CR
LTQ@LTP
450@24.70
ATP
23.88
Var Margin
100 %
Circuit Range
23.39-25.85
Delivery %
0 %
Value
3.03 L
ASM/GSM
No
Market Lot
1

Venmax Drugs And Pharmaceuticals Futures & Options

Data Not Found

Venmax Drugs And Pharmaceuticals Corporate Actions

DateAgenda
2025-05-09Audited Results
2025-02-08Quarterly Results
2025-01-11Preferential issue of shares
DateEvent TypeAgenda
2025-05-09Board MeetingAudited Results
2025-02-08Board MeetingQuarterly Results
2025-01-11Board MeetingPreferential issue of shares

Venmax Drugs And Pharmaceuticals News

No Data Found

About Venmax Drugs And Pharmaceuticals

NSE : 0  
BSE : 531015  
ISIN : INE154G01022  

Yenkey Drugs and Pharmaceuticals Ltd. was originallyincorporated on 28th September 1988 in the name of YenkeyMedico Drugs Private Limited. The Company has beenconverted into a public limited company on 3rd Feb''95 interms of a special resolution passed on 23.01.95 underSection 31(1)/44 of the Companies Act 1956. Accordinglythe Company has obtained a fresh Certificate ofIncorporation consequent on the conversion from theRegistrar of Companies Andhra Pradesh vide ref. no.01-09102 dated 3rd February 1995.The Company is producing bulk drug intermediates asdetailed above and marketing in the domestic markets. Thetotal turnover of the Company is Rs. 89.70 lacs for theyear ended March 1994. Now the Company proposes to expandthe existing capacity of dye and drug intermediate viz; ECAand diversifying into manufacturing of high value chemicalsand bulk drugs viz; Sodium Azide and Vitamin B2 Phosphate.The Company is also proposing to set up a R & D Unit formaintaining high quality control standards of foreignbuyers.

Venmax Drugs And Pharmaceuticals Management

NamePosition
Mr. N Krishnaiah Managing Director
Dr. A Ramakrishnaiah Independent Director
Mrs. P Meena Kumari Addnl.Non Exe.Independent Director
Mr. Gundluru Reddappa Addnl.Non Exe.Independent Director
Mr. Swapneshwar Mishra Additional Non Exe.Non Ind.Director
Read More

Venmax Drugs And Pharmaceuticals Similar Stocks

No Data Found

Venmax Drugs And Pharmaceuticals FAQs

The Buying Price of Venmax Drugs And Pharmaceuticals share is 24.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Venmax Drugs And Pharmaceuticals share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Venmax Drugs And Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Venmax Drugs And Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Venmax Drugs And Pharmaceuticals’s valuation compare Sector P/E, P/B which are 37.02 & 3.95 with sector averages, along with growth rates and financial metrics.

The Market Cap of Venmax Drugs And Pharmaceuticals is 12.90 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Venmax Drugs And Pharmaceuticals share price is 30.88 & 6.27. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.